← Back to Search

Other

Higher protein, low glycemic load diet for Metabolic Syndrome (MAPS Trial)

N/A

Waitlist Available

Research Sponsored by University of Arkansas, Fayetteville

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline at 16 weeks

Awards & highlights

MAPS Trial Summary

This trial will test if regular potato consumption can improve cardiometabolic health in individuals with MetS.

Eligible Conditions

Metabolic Syndrome

MAPS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline at 16 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline at 16 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Plasma glucose levels

Serum lipid levels

Secondary outcome measures

Appetite

Dietary intake

Marker of appetite and sleep

+4 more

MAPS Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Higher Protein, Low Glycemic Load with PotatoesExperimental Treatment1 Intervention

Higher Protein, Low Glycemic Load with Potatoes (HPLG-P): low- to moderate- glycemic load meals containing white potatoes. Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing white potatoes.

Group II: Higher Protein, Low Glycemic Load with Processed PotatoesActive Control1 Intervention

Higher Protein, Low Glycemic Load with Processed Potatoes (HPLG-PP): low- to moderate- glycemic load meals containing processed white potato products. Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing white potatoes.

Group III: Higher Protein, Low Glycemic Load - ControlPlacebo Group1 Intervention

Higher Protein, Low Glycemic Load (HPLG-C): low- to moderate- glycemic load meals containing control carbohydrate (e.g. rice, pasta). Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing control carbohydrate sources.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Arkansas, FayettevilleLead Sponsor

20 Previous Clinical Trials

1,625 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of participants involved in this medical experiment?

"Correct. By consulting clinicaltrials.gov, it is visible that this medical experiment has been in search of participants since June 1st 2019 and was recently updated on June 16th 2021. This trial requires 90 individuals to be recruited from a single healthcare centre."

Answered by AI

To which demographics is enrollment for this clinical trial accessible?

"This clinical research is accepting 90 members, aged between 18 and 85 that have metabolic syndrome. To be eligible for the trial, participants must meet certain conditions: living in Northwest Arkansas, being of any ethnicity or gender, and consuming a high glycemic load diet."

Answered by AI

What aims does this investigation seek to achieve?

"This 16-week experiment evaluates serum lipid levels as its primary outcome. Secondary data points include sleep duration (measured by an Actigraph), dietary intake (via monthly food records), and a Pittsburgh Sleep Quality Index to assess overall quality of rest."

Answered by AI

Are there any opportunities for people to partake in this research?

"Affirmative. As per the information stored on clinicaltrials.gov, this medical trial is currently signing up participants and was originally publicised on June 1st 2019. 90 test subjects are expected to be enrolled from one health facility before its most recent update of 16th June 2021."

Answered by AI